<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Idiopathic <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo> (iCVT) represents approximately 30% of the cases of <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo> (CVT) </plain></SENT>
<SENT sid="1" pm="."><plain>New, inherited - factor V Leiden (FVL) and prothrombin gene mutation (PTHRA20210) - and inherited/acquired - <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> (HHcy) - prothrombotic conditions have been detected recently </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We assessed fasting plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) levels and main <z:chebi fb="0" ids="17230">Hcy</z:chebi> determinants, FVL and PTHRA(20210) in 30 patients with documented iCVT and 40 age- and sex-matched healthy subjects </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A strong and significant association of PTHRA(20210) [30% (9/30) vs. 2.5% (1/40) iCVT vs. controls, respectively, p = 0.001; OR = 16.174, p = 0.002] and HHcy [13/30 (43.3%) vs. 4/40 (10%) iCVT vs. controls, respectively; p = 0.002, OR = 6.88, p = 0.002] with iCVT was found </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: PTHRA(20210) and HHcy should be considered when screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and should be assessed in patients with a family or personal history of CVT </plain></SENT>
</text></document>